BWXT Medical,a subsidiary of BWX Technologies(BWXT), entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere Y-90 Glass Microspheres for Boston...
Abiomed is trading lower after Raymond James noted a potential impact on its biggest revenue generator Impella citing a new clinical trial posted by Boston...
Regarding the trend, note that the strongest trend exists on the 100 hour timeframe.The post Boston Scientific Corp (BSX): Price Now Near $43.84; Daily Chart Shows An Uptrend on...
Boston Scientific Corporation (NYSE:BSX) BSX posted adjusted earnings per share (EPS) of 37 cents for the first quarter of 2021, which marked a 32.1% surge from the year-ago...
Boston Scientific Corp (NYSE:BSX) is surging today. Shares were up more than 3% at midday following positive analyst comments: “Atlantic equities started coverage with an...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 306.53 | 306.84 | 299.69 | +0.56 | +0.18% | 18.92M | NASDAQ | |||
| 2,270.06 | 2,280.28 | 2,233.92 | -21.69 | -0.95% | 1.71M | NASDAQ | |||
| 221.38 | 221.39 | 213.00 | +1.85 | +0.84% | 13.89M | NYSE | |||
| 0.0238 | 0.00 | 0.00 | -0.00060 | -2.46% | 14.18M | OTC Markets | |||
| 33.16 | 33.16 | 32.93 | -0.65 | -1.92% | 16.47K | OTC Markets | |||
| 145.10 | 147.13 | 143.79 | -2.74 | -1.85% | 553.80K | NYSE | |||
| 24.04 | 24.13 | 23.92 | -0.36 | -1.49% | 27.10K | OTC Markets | |||
| 18.20 | 18.20 | 18.20 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 0.013 | 0.00 | 0.00 | -0.002 | -10.88% | 8.00K | OTC Markets | |||
| 42.23 | 42.44 | 42.06 | -0.52 | -1.22% | 55.26K | OTC Markets | |||
| 290.53 | 290.77 | 286.61 | -0.83 | -0.28% | 308.44K | NYSE | |||
| 20.34 | 20.36 | 20.00 | +0.34 | +1.70% | 751.00 | NASDAQ | |||
| 11.94 | 11.96 | 11.84 | -0.26 | -2.13% | 49.40K | OTC Markets | |||
| 16.18 | 16.18 | 16.01 | -0.09 | -0.57% | 13.87K | OTC Markets | |||
| 21.69 | 21.69 | 21.69 | +0.05 | +0.23% | 240.00 |
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.